Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yaling Tang

Showing results (81-90 of 83) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 83 results.
Acta Diabetologica|February 3, 2022
Pathogenic variants of MODY-genes in adult patients with early-onset type 2 diabetesSerena Pezzilli, Tommaso Mazza, Maria Giovanna Scarale, et al.
Diabetes & Metabolism|April 29, 2022
Contribution of rare variants in monogenic diabetes-genes to early-onset type 2 diabetesSerena Pezzilli, Manoush Tohidirad, Tommaso Biagini, et al.
Med (New York, N.Y.)|January 19, 2025
IBI310 plus sintilimab vs. placebo plus sintilimab in recurrent/metastatic cervical cancer: A double-blind, randomized controlled trialHuayi Li, Yu Xu, Xiaofei Jiao, et al.
Pageof 9

Showing results (81-90 of 83) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 83 results.
Acta Diabetologica|February 3, 2022
Pathogenic variants of MODY-genes in adult patients with early-onset type 2 diabetesSerena Pezzilli, Tommaso Mazza, Maria Giovanna Scarale, et al.
Diabetes & Metabolism|April 29, 2022
Contribution of rare variants in monogenic diabetes-genes to early-onset type 2 diabetesSerena Pezzilli, Manoush Tohidirad, Tommaso Biagini, et al.
Med (New York, N.Y.)|January 19, 2025
IBI310 plus sintilimab vs. placebo plus sintilimab in recurrent/metastatic cervical cancer: A double-blind, randomized controlled trialHuayi Li, Yu Xu, Xiaofei Jiao, et al.
Pageof 9